Targeted Protein Degradation Of Parp14 For Use In Therapy

Patent No. EP3986887 (titled "Targeted Protein Degradation Of Parp14 For Use In Therapy") was filed by Abbvie Biotechnology on Jun 18, 2020. The application was issued on Apr 27, 2022.

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3986887

ABBVIE BIOTECHNOLOGY
Application Number
EP20737701A
Filing Date
Jun 18, 2020
Status
Request For Examination Was Made
Mar 25, 2022
Publication Date
Apr 27, 2022